Rhonda Meisner v. ZymoGenetics Incorporated

Filing

UNPUBLISHED PER CURIAM OPINION filed. Originating case number: 3:12-cv-00684-CMC. Copies to all parties and the district court. [999638111]. Mailed to: Rhonda Meisner. [14-2396]

Appeal: 14-2396

Doc: 36

Filed: 08/11/2015

Pg: 1 of 2

UNPUBLISHED
UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT

No. 14-2396

RHONDA MEISNER,
Plaintiff - Appellant,
v.
ZYMOGENETICS INCORPORATED, a wholly owned subsidiary of
Bristol-Myers Squibb; TRACEY CALDERAZZO; ZYMOGENETICS LLC, a
wholly owned subsidiary of ZymoGenetics, Inc,
Defendants - Appellees.

Appeal from the United States District Court for the District of
South Carolina, at Columbia.
Cameron McGowan Currie, Senior
District Judge. (3:12-cv-00684-CMC)

Submitted:

July 28, 2015

Decided:

August 11, 2015

Before WILKINSON, NIEMEYER, and AGEE, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Rhonda Meisner, Appellant Pro Se. Stephanie E. Lewis, Jonathan
A. Roth, JACKSON LEWIS PC, Greenville, South Carolina, for
Appellees.

Unpublished opinions are not binding precedent in this circuit.

Appeal: 14-2396

Doc: 36

Filed: 08/11/2015

Pg: 2 of 2

PER CURIAM:
Rhonda Meisner appeals the district court’s order accepting
the

recommendation

judgment

to

of

the

Appellees,

magistrate

and

judge,

affirming

the

granting

summary

magistrate

judge’s

denial of her motion to amend in her action alleging employment
discrimination

and

related

state-law

claims.

Meisner

also

appeals the district court’s orders denying her Fed. R. Civ. P.
59(e) motion and taxing costs to her.
record and find no reversible error.
the

reasons

ZymoGenetics,

stated

by

Inc.,

No.

the

We have reviewed the

Accordingly, we affirm for

district

court.

3:12-cv-00684-CMC

2014; Nov. 25, 2014; Dec. 2, 2014).

(D.S.C.

Meisner

v.

Sept.

22,

We dispense with oral

argument because the facts and legal contentions are adequately
presented in the materials before this court and argument would
not aid the decisional process.
AFFIRMED

2